Clinical Trial or Patient Registry? Why the Difference Matters When Evaluating a Stem Cell Clinic

Many clinics offering unproven stem cell interventions describe them as part of a "registry study" or "observational study" rather than a true FDA-regulated clinical trial — and the difference is not just paperwork. A real trial involves federal oversight, a defined scientific protocol, and specific protections for participants; a registry is typically just a database of patient information with none of those requirements. This article explains what separates the two, how to verify which one you're actually being offered, and what questions to ask before you enroll or pay anything.

What a Real Clinical Trial Actually Requires

A legitimate clinical trial testing an investigational stem cell product is regulated by the FDA as a drug or biologic. Under federal regulation (21 CFR 312.20), a sponsor must submit an Investigational New Drug (IND) application to the FDA and cannot begin human testing until that IND is in effect. The FDA has repeatedly stated that administering these products requires an IND, with safety oversight built in before any patient is treated. A real trial also requires independent Institutional Review Board (IRB) approval of the protocol and informed consent documents, proceeds through defined phases (Phase I for safety, Phase II/III for effectiveness, often against a comparison group), and is generally required to register on ClinicalTrials.gov under the FDA Amendments Act (FDAAA 801) — specifically, controlled trials of FDA-regulated drugs/biologics beyond Phase I, and any NIH-funded trial regardless of phase.

What a "Registry" or "Observational Study" Is — and Isn't

A patient registry is, at its core, a database that collects information about people who share a condition or have undergone a procedure — researchers use it to study a disease or track outcomes, not to test whether a treatment works against a defined endpoint. An observational study follows people who receive a treatment as part of routine practice, without the FDA oversight, control group, or randomization that a true interventional trial requires. Neither a registry nor most observational studies require an IND, because by design they aren't testing an unapproved product for FDA approval — they're simply gathering data. That distinction is exactly what some clinics exploit: by calling their offering a "registry" or "observational study," they can administer an unapproved product and collect a fee from patients without ever going through the far more demanding IND and IRB process a genuine trial requires.

How to Check ClinicalTrials.gov Yourself

ClinicalTrials.gov is a free, searchable database maintained by the National Library of Medicine at NIH. You can search by condition, location, or sponsor name and read a study's phase, recruitment status, listed interventions, and eligibility criteria. But a listing alone proves less than most patients assume: NIH's own guidance states plainly, "Listing a study does not mean it has been evaluated by the U.S. Federal Government." The registry performs only a limited administrative quality check on submitted data — it does not independently verify a study's scientific validity. Investigative reporting has documented clinics whose studies stayed listed as "Recruiting" on ClinicalTrials.gov even after FDA enforcement action, with listings that never disclosed that patients had been seriously injured. So treat a ClinicalTrials.gov listing as a starting point for verification, not proof of legitimacy — check the phase (Phase I-only or unspecified-phase studies are not yet testing effectiveness), the sponsor, whether it's marked as an "Applicable Clinical Trial" under FDAAA 801, and whether the listed FDA oversight status matches what the clinic is telling you.

Red Flags: When "Registry" Language Signals a Problem

Being charged a fee to receive the product itself — rather than reimbursement of minor logistical costs — is one of the clearest signals that you are not in a legitimate IND-regulated trial; the FDA specifically warns that being charged for these products, or being offered them outside a trial with FDA oversight, suggests deception. Other signals: no mention of an IND, no IRB named in your consent paperwork, no control or comparison group, and marketing language that treats a ClinicalTrials.gov listing as if it were an FDA endorsement.

Questions to Ask Before You Enroll

• Is this treatment part of an FDA-regulated trial conducted under an active IND, and can the clinic produce that IND number?
• Which IRB approved this study, and can I contact them directly?
• Is this an interventional trial with a comparison/control group, or an observational registry that only collects data?
• Will I be charged to receive the product itself, and if so, why — real trials typically do not bill patients for the investigational treatment?
• What is this study's exact status and phase on ClinicalTrials.gov, and does that match what I'm being told verbally?
• What specific endpoints is this study measuring, and when/how will results be reported?

Bottom Line

"Registry" and "clinical trial" are not interchangeable, and the difference determines whether you have real federal oversight, informed-consent protections, and a scientifically defined endpoint — or simply a data-collection exercise attached to an unapproved, fee-based procedure. Before agreeing to anything, ask directly about the IND, the IRB, and the ClinicalTrials.gov listing, and be skeptical of any clinic that can't answer clearly.